News
FOCUS Newsletter September 2009
To our Sponsors - update from FOCUS Clinical Drug Development GmbH
[ more ]FOCUS Newsletter July 2009
[ more ]FOCUS - Interview CW Weekly
[ more ]The major success factors to achieve EU pharmaceutical product registration for Indian pharmaceutical products
The Indian pharmaceutical industry has made great progress and moved up the value chain from generics to discovery-based R&D. Time and budgetary constraints urge Indian pharmaceutical companies to look for smart approaches to find the right development and registration processes for their products and achieve key milestones fast.
FOCUS...
[ more ]FOCUS has introduced three urinary biomarkers for detection and monitoring of renal injury:
alpha-GST is a cystolic protein highly specific for the cells of the proximal renal tubules. There it is found in high concentrations and is readily released into the urine in the event of renal tubular injury. Urinary alpha-GST is a highly sensitive and specific biomarker of proximal tubular injury.
phi-GST is specific for cells...
